TMDIF vs. DRTS, CATX, KRMD, NVRO, OBIO, BWAY, SKIN, PROF, INFU, and TLSI
Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), KORU Medical Systems (KRMD), Nevro (NVRO), Orchestra BioMed (OBIO), BrainsWay (BWAY), Beauty Health (SKIN), Profound Medical (PROF), InfuSystem (INFU), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.
Titan Medical vs.
Alpha Tau Medical (NASDAQ:DRTS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.
Alpha Tau Medical received 19 more outperform votes than Titan Medical when rated by MarketBeat users.
Alpha Tau Medical has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.
In the previous week, Alpha Tau Medical had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Titan Medical. Alpha Tau Medical's average media sentiment score of 1.35 beat Titan Medical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.
Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 198.51%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Alpha Tau Medical is more favorable than Titan Medical.
Alpha Tau Medical's return on equity of -38.62% beat Titan Medical's return on equity.
2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Titan Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Alpha Tau Medical beats Titan Medical on 10 of the 14 factors compared between the two stocks.
Get Titan Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
TMDIF vs. The Competition
Titan Medical Competitors List
Related Companies and Tools
This page (NASDAQ:TMDIF) was last updated on 2/22/2025 by MarketBeat.com Staff